Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Journal of Medical Economics|January 24, 2020
Cost-utility analyses of targeted immunomodulators in rheumatoid arthritis: systematic reviewMatthew Sussman, Charles Tao, Pankaj Patel, et al.Journal of Affective Disorders|February 14, 2012
The relationship between use of antidepressants and resource utilization among patients with manic or mixed bipolar disorder episodes: findings from a managed care settingMatthew Sussman, Mark Friedman, Jonathan R Korn, et al.Journal of Medical Economics|March 5, 2025
Autologous skin cell suspension plus phototherapy in stable vitiligo: findings from a US economic modelJennifer Benner, Nicholas Adair, Brian Hitt, et al.Journal of Vascular and Interventional Radiology : JVIR|January 30, 2013
Failure of surgical and endovascular infrainguinal and iliac procedures in the management of peripheral arterial disease using data from electronic medical recordsMatthew Sussman, Rajiv Mallick, Mark Friedman, et al.Journal of Affective Disorders|January 7, 2023
The impact of early remission on disease trajectory and patient outcomes in major depression disorder (MDD): A targeted literature review and microsimulation modeling approach based on the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) studyAlix Arnaud, Jennifer Benner, Ellison Suthoff, et al.Journal of the American Heart Association|November 27, 2013
Impact of atrial fibrillation on stroke-related healthcare costsMatthew Sussman, Joseph Menzin, Iris Lin, et al.Journal of Medical Economics|June 13, 2026
Potential implications of increased utilization of oral nirmatrelvir/ritonavir in outpatient care for COVID-19: modeled findings from the Spanish National Health System perspectiveJennifer Benner, Jackie Lee, Laura Cianciolo, et al.Orphanet Journal of Rare Diseases|May 14, 2025
Treatment preferences among individuals with primary hyperoxaluria type 1 (PH1): a real-world studyDavid S Goldfarb, Jing Voon Chen, Rebekah Zincavage, et al.Journal of Market Access & Health Policy|November 26, 2024
Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling ApproachMatthew Sussman, Jennifer Benner, Tendai Mugwagwa, et al.Journal of Affective Disorders|October 4, 2016
Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorderMatthew Sussman, Jeffrey Yu, Siddhesh A Kamat, et al.Pageof 4